January 1, 2000Muscle & Nerve

Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome

View Full Paper

Ask AI

Bookmark

Population

4 patients with Crow-Fukase syndrome (CFS)

Design

Case_series

Authors

THTeruto HashiguchiKagoshima University KAKimiyoshi ArimuraKagoshima University Hospital KMKenji MatsumuroKagoshima University

Discussion

Member takes

Implication

Supports platelet origin of VEGF in Crow-Fukase syndrome; hypothesis-generating and requires confirmation before clinical consideration.

Structured PICO

Population

4 patients with Crow-Fukase syndrome (CFS)

Outcome

Difference in concentration of vascular endothelial growth factor (VEGF) between serum and plasmasurrogate

Platelets are a major source of excessive VEGF in Crow-Fukase syndrome, which is released during platelet aggregation and may contribute to the disease's vascular manifestations.

Cite This Study

Hashiguchi et al. (2000) studied this question.

synapsesocial.com/papers/6a884d3b054eefc4d777001c https://doi.org/10.1002/1097-4598(200007)23:7<1051::aid-mus7>3.0.co;2-v

View Full Paper

Ask AI

Bookmark

Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider